chr12-88148325-A-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_181783.4(TMTC3):āc.10A>Gā(p.Ile4Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,607,506 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_181783.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMTC3 | NM_181783.4 | c.10A>G | p.Ile4Val | missense_variant | 2/14 | ENST00000266712.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMTC3 | ENST00000266712.11 | c.10A>G | p.Ile4Val | missense_variant | 2/14 | 1 | NM_181783.4 | P1 | |
TMTC3 | ENST00000547034.5 | c.10A>G | p.Ile4Val | missense_variant, NMD_transcript_variant | 2/12 | 1 | |||
TMTC3 | ENST00000549011.5 | c.10A>G | p.Ile4Val | missense_variant | 2/4 | 4 | |||
TMTC3 | ENST00000551088.1 | c.10A>G | p.Ile4Val | missense_variant | 2/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000489 AC: 12AN: 245240Hom.: 0 AF XY: 0.0000605 AC XY: 8AN XY: 132216
GnomAD4 exome AF: 0.000129 AC: 188AN: 1455338Hom.: 0 Cov.: 30 AF XY: 0.000116 AC XY: 84AN XY: 723532
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74340
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 21, 2022 | The c.10A>G (p.I4V) alteration is located in exon 2 (coding exon 1) of the TMTC3 gene. This alteration results from a A to G substitution at nucleotide position 10, causing the isoleucine (I) at amino acid position 4 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 4 of the TMTC3 protein (p.Ile4Val). This variant is present in population databases (rs146954242, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with TMTC3-related conditions. ClinVar contains an entry for this variant (Variation ID: 1033238). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Lissencephaly 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 07, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at